US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist

1.9100
-0.0200-1.04%

Close Mar 28 16:00 ET

1.9200
+0.0100+0.52%

Post 20:01 ET

498.95MMarket Cap-5.79P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akebia Therapeutics Q4 2024 Earnings Date

Currency：USDMar 13, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	37.36M	46.50M	+9.14M
Beat Est.	-33.52%	-17.26%	+24.47%
EPS	-0.08	-0.10	-0.02
Miss Est.	--	-3207.52%	-25.16%

Analyst Rating

Strong Buy

Mar 15, 2025

Akebia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 44.135M	--
--	2025/Q1	-- / 44.376M	--
Mar 13, 2025	2024/Q4	46.497M / 37.356M	--
Nov 7, 2024	2024/Q3	37.428M / 44.505M	--
Aug 8, 2024	2024/Q2	43.648M / 43.653M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 44.135M--

--2025/Q1-- / 44.376M--

Mar 13, 20252024/Q446.497M / 37.356M--

Nov 7, 20242024/Q337.428M / 44.505M--

Aug 8, 20242024/Q243.648M / 43.653M--

Unlock Free Earnings Estimates

Open Account

Akebia Therapeutics Earnings Reports

Akebia Therapeutics | 10-K: FY2024 Annual Report

Mar 13 07:28 ET

Akebia Therapeutics | 8-K: Akebia Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Vafseo® (vadadustat) Commercial Launch Progress Update

Mar 13 07:09 ET

Akebia Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 07:18 ET

Akebia Therapeutics | 8-K: Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 7, 2024 07:08 ET